Incyte to Report Second Quarter Financial Results

Rhea-AI Summary

Incyte (Nasdaq: INCY) will release its Q2 2024 financial results on July 30, 2024, at 7:00 a.m. ET. A conference call and webcast to discuss these results will follow at 8:00 a.m. ET. Domestic participants can dial in at 877-407-3042, while international participants can use 201-389-0864, with the conference ID 13747471. For those unable to attend, a replay will be available for thirty days by dialing 877-660-6853 (U.S.) or 201-612-7415 (international) and using the same conference ID. The live webcast and slides can be accessed at Investor.Incyte.com and will be available for replay for ninety days.

Positive

• None.

WILMINGTON, Del.--(BUSINESS WIRE)-- Incyte (Nasdaq:INCY) announced today that it has scheduled its second quarter financial results conference call and webcast for 8:00 a.m. ET on Tuesday, July 30, 2024.

The schedule for the press release and conference call/webcast is as follows:

• Q2 2024 Press Release: July 30, 2024 at 7:00 a.m. ET
• Q2 2024 Conference Call: July 30, 2024 at 8:00 a.m. ET
• Domestic Dial-In Number: 877-407-3042
• International Dial-In Number: 201-389-0864
• Conference ID Number: 13747471

If you are unable to participate, a replay of the conference call will be available for thirty days. The replay dial-in number for the U.S. is 877-660-6853 and the dial-in number for international callers is 201-612-7415. To access the replay you will need the conference ID number 13747471.

The live webcast with slides can be accessed at Investor.Incyte.com and will be available for replay for ninety days.

About Incyte

A global biopharmaceutical company on a mission to Solve On., Incyte follows the science to find solutions for patients with unmet medical needs. Through the discovery, development and commercialization of proprietary therapeutics, Incyte has established a portfolio of first-in-class medicines for patients and a strong pipeline of products in Oncology and Inflammation & Autoimmunity. Headquartered in Wilmington, Delaware, Incyte has operations in North America, Europe and Asia.

For additional information on Incyte, please visit Incyte.com or follow us on social media: LinkedIn, X, Instagram, Facebook, YouTube.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240709787662/en/

Media

media@incyte.com

Investors

ir@incyte.com

Source: Incyte

FAQ

When will Incyte report its Q2 2024 financial results?

Incyte will report its Q2 2024 financial results on July 30, 2024, at 7:00 a.m. ET.

What is the date and time for Incyte's Q2 2024 conference call?

The conference call for Incyte's Q2 2024 financial results will be held on July 30, 2024, at 8:00 a.m. ET.

How can domestic participants join Incyte's Q2 2024 conference call?

Domestic participants can join Incyte's Q2 2024 conference call by dialing 877-407-3042 and using the conference ID 13747471.

What is the international dial-in number for Incyte's Q2 2024 conference call?

International participants can join Incyte's Q2 2024 conference call by dialing 201-389-0864 and using the conference ID 13747471.

How can one access the replay of Incyte's Q2 2024 conference call?

The replay of Incyte's Q2 2024 conference call can be accessed for thirty days by dialing 877-660-6853 (U.S.) or 201-612-7415 (international) with the conference ID 13747471.

Where can you view the live webcast of Incyte's Q2 2024 financial results?

The live webcast of Incyte's Q2 2024 financial results can be viewed at Investor.Incyte.com and will also be available for replay for ninety days.